Clinical Trial Update: AqueSys Microfistula Implant in Refractory Glaucoma [Phase 3]

View source ↗

Summary

Phase 3 trial of the AqueSys Microfistula Implant for refractory open-angle glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Open-angle Glaucoma

Drugs mentioned

• AqueSys Microfistula Implant

Snippet

Sponsor: AqueSys, Inc. | Conditions: Glaucoma, Glaucoma, Open-Angle | Phase 3 | Status: COMPLETED